Suppr超能文献

哺乳动物 LATS/NDR 激酶的调控与功能:超越经典 Hippo 信号通路的研究。

Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.

机构信息

Tumour Suppressor Signalling Networks laboratory, UCL Cancer Institute, University College London, London WC1E 6BT, UK.

出版信息

Cell Biosci. 2013 Aug 28;3(1):32. doi: 10.1186/2045-3701-3-32.

Abstract

The metazoan Hippo pathway is an essential tumour suppressor signalling cascade that ensures normal tissue growth by co-ordinating cell proliferation, cell death and cell differentiation. Over the past years, various genetic and biochemical studies in Drosophila and mammals have defined a conserved core Hippo signalling module, composed of members of the Ste20-like kinase, the MOB co-activator and the AGC kinase families. In Drosophila, stimulated Hippo kinase phosphorylates and thereby activates the Mats/Warts complex, which consequently phosphorylates and inactivates the transcriptional co-activator Yorkie. In mammals, the counterparts of the Hippo/Mats/Warts/Yorkie cascade, namely MST1/2, MOB1A/B, LATS1/2 and YAP/TAZ, function in a similar fashion. These canonical Hippo pathways are so highly conserved that human MST2, hMOB1A and LATS1 can compensate for the loss of Hippo, Mats and Warts in flies. However, recent reports have shown that Hippo signalling is more diverse and complex, in particular in mammals. In this review, we summarize our current understanding of mammalian LATS1/2 kinases together with their closest relatives, the NDR1/2 kinases. The regulation of the LATS/NDR family of kinases will be discussed, followed by a summary of all currently known LATS/NDR substrates. Last, but not least, the biological roles of LATS/NDR kinases will be reviewed with specific emphasis on recent discoveries of canonical and non-canonical LATS/NDR functions in the extended Hippo pathway.

摘要

后生动物 Hippo 途径是一种重要的肿瘤抑制信号级联反应,通过协调细胞增殖、细胞死亡和细胞分化来确保组织的正常生长。在过去的几年中,果蝇和哺乳动物中的各种遗传和生化研究定义了一个保守的核心 Hippo 信号模块,由 Ste20 样激酶、MOB 激活子和 AGC 激酶家族的成员组成。在果蝇中,受刺激的 Hippo 激酶磷酸化并激活 Mats/Warts 复合物,随后磷酸化并失活转录共激活因子 Yorkie。在哺乳动物中,Hippo/Mats/Warts/Yorkie 级联的对应物,即 MST1/2、MOB1A/B、LATS1/2 和 YAP/TAZ,以类似的方式发挥作用。这些经典的 Hippo 途径高度保守,以至于人类 MST2、hMOB1A 和 LATS1 可以补偿果蝇中 Hippo、Mats 和 Warts 的缺失。然而,最近的报告表明 Hippo 信号更为多样化和复杂,特别是在哺乳动物中。在这篇综述中,我们总结了我们目前对哺乳动物 LATS1/2 激酶及其最接近的亲属 NDR1/2 激酶的理解。将讨论 LATS/NDR 激酶家族的调节,随后总结所有目前已知的 LATS/NDR 底物。最后但同样重要的是,将审查 LATS/NDR 激酶的生物学作用,特别强调 Hippo 途径扩展中经典和非经典 LATS/NDR 功能的最新发现。

相似文献

2
Protein kinases of the Hippo pathway: regulation and substrates.Hippo 通路中的蛋白激酶:调控与底物
Semin Cell Dev Biol. 2012 Sep;23(7):770-84. doi: 10.1016/j.semcdb.2012.07.002. Epub 2012 Aug 9.
6
The NDR/LATS protein kinases in immunology and cancer biology.NDR/LATS 蛋白激酶在免疫学和肿瘤生物学中的作用。
Semin Cancer Biol. 2018 Feb;48:104-114. doi: 10.1016/j.semcancer.2017.04.010. Epub 2017 Jun 1.
7
The Hippo pathway in disease and therapy: cancer and beyond.Hippo 通路与疾病和治疗:癌症及其他。
Clin Transl Med. 2014 Jul 10;3:22. doi: 10.1186/2001-1326-3-22. eCollection 2014.
8
9
Tumor suppressor LATS1 is a negative regulator of oncogene YAP.肿瘤抑制因子LATS1是致癌基因YAP的负调控因子。
J Biol Chem. 2008 Feb 29;283(9):5496-509. doi: 10.1074/jbc.M709037200. Epub 2007 Dec 24.

引用本文的文献

7
Discovery of a small-molecule NDR1 agonist for prostate cancer therapy.发现一种用于前列腺癌治疗的小分子NDR1激动剂。
Front Pharmacol. 2024 Feb 12;15:1367358. doi: 10.3389/fphar.2024.1367358. eCollection 2024.

本文引用的文献

8
The Hippo pathway and human cancer.Hippo 通路与人类癌症。
Nat Rev Cancer. 2013 Apr;13(4):246-57. doi: 10.1038/nrc3458. Epub 2013 Mar 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验